Effect of intraperitoneal acetyl-L-carnitine (ALCAR) on anxiety-like behaviours in rats

Joseph Levine, Zeev Kaplan, Jay W. Pettegrew, Richard J. McClure, Samuel Gershon, Igor Buriakovsky, Hagit Cohen

    Research output: Contribution to journalArticlepeer-review

    12 Scopus citations


    Acetyl-L-carnitine (ALCAR) is an acetyl derivative of carnitine, an endogenous molecule synthesized in vivo and supplemented by diet (mainly via meat and dairy products). Several parallel, double-blind, placebo-controlled studies have demonstrated that ALCAR treatment produces beneficial effects in geriatric depression. Since most antidepressants also have anti-anxiety effects we examined whether ALCAR shows anti-anxiety effects in a rat model of anxiety. Compared to a saline-injected control group, chronic administration of ALCAR at doses of 10 and 100 mg/kg (tested 24 h after the last dose administration) showed no effects, whereas doses of 50 and 75 mg/kg significantly reduced anxiety-like behaviours in the elevated plus-maze. Acute ALCAR (100 mg/kg), on the other hand (tested 6 h after administration), demonstrated anxiogenic effects. Our data suggest that chronic ALCAR administration may produce an inverted U-shaped curve of dose-dependent changes in anxiety-like behaviour. The precise mechanism by which ALCAR decreases anxiety-like behaviour after peripheral administration remains to be determined.

    Original languageEnglish
    Pages (from-to)65-74
    Number of pages10
    JournalInternational Journal of Neuropsychopharmacology
    Issue number1
    StatePublished - 1 Mar 2005


    • Acetyl carnitine
    • Animal
    • Anxiety disorders
    • Models

    ASJC Scopus subject areas

    • Pharmacology
    • Psychiatry and Mental health
    • Pharmacology (medical)


    Dive into the research topics of 'Effect of intraperitoneal acetyl-L-carnitine (ALCAR) on anxiety-like behaviours in rats'. Together they form a unique fingerprint.

    Cite this